{"id":353152,"date":"2026-11-18T15:45:01","date_gmt":"2026-11-18T10:15:01","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=353152"},"modified":"2026-11-18T15:45:01","modified_gmt":"2026-11-18T10:15:01","slug":"pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/","title":{"rendered":"3 Pharmaceuticals Company, Shopping Malls Owner and Dairy Products Company Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Phoenix Mills and Dodla Dairy"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Alembic Pharmaceuticals, Phoenix Mills and Dodla Dairy: ROE of 11.1% to 15.9% and FY22 to FY26 revenue CAGR of 8.4% to 31.0%. Prices as of 17 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three <strong>tablet maker, shopping mall and milk stocks<\/strong> to watch are <strong>Alembic Pharmaceuticals<\/strong>, <strong>Phoenix Mills<\/strong> and <strong>Dodla Dairy<\/strong>. Their <strong>return on equity<\/strong> ranges from <strong>11.1% to 15.9%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 8.4% to 31.0%. Dodla Dairy has the highest return on equity at 15.9%, while Phoenix Mills has the fastest revenue growth at 31.0% a year. Prices are based on the 17 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Tablet maker, shopping mall and milk stocks let investors follow companies that serve a growing part of the Indian economy. Alembic Pharmaceuticals, Phoenix Mills and Dodla Dairy cover a pharmaceuticals company, a shopping malls owner and a dairy products company.<\/p>\n<p>This list covers three tablet maker, shopping mall and milk stocks with complete current figures: Alembic Pharmaceuticals, Phoenix Mills and Dodla Dairy. Every figure comes from the latest reported financials and the 17 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#What_Are_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\" title=\"What Are Tablet Maker, Shopping Mall and Milk Stocks?\">What Are Tablet Maker, Shopping Mall and Milk Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Tablet_Maker_Shopping_Mall_and_Milk_Stocks_at_a_Glance\" title=\"Tablet Maker, Shopping Mall and Milk Stocks at a Glance\">Tablet Maker, Shopping Mall and Milk Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Why_Do_Tablet_Maker_Shopping_Mall_and_Milk_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Tablet Maker, Shopping Mall and Milk Stocks Have a Strong Roadmap in India?\">Why Do Tablet Maker, Shopping Mall and Milk Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Why_Alembic_Pharmaceuticals_Features_Among_These_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\" title=\"Why Alembic Pharmaceuticals Features Among These Tablet Maker, Shopping Mall and Milk Stocks\">Why Alembic Pharmaceuticals Features Among These Tablet Maker, Shopping Mall and Milk Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Why_Phoenix_Mills_Features_Among_These_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\" title=\"Why Phoenix Mills Features Among These Tablet Maker, Shopping Mall and Milk Stocks\">Why Phoenix Mills Features Among These Tablet Maker, Shopping Mall and Milk Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Why_Dodla_Dairy_Features_Among_These_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\" title=\"Why Dodla Dairy Features Among These Tablet Maker, Shopping Mall and Milk Stocks\">Why Dodla Dairy Features Among These Tablet Maker, Shopping Mall and Milk Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Alembic_Pharmaceuticals_vs_Phoenix_Mills_vs_Dodla_Dairy_on_Key_Financials\" title=\"Alembic Pharmaceuticals vs Phoenix Mills vs Dodla Dairy on Key Financials\">Alembic Pharmaceuticals vs Phoenix Mills vs Dodla Dairy on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Key_Risks_to_Check_Before_Investing_in_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\" title=\"Key Risks to Check Before Investing in Tablet Maker, Shopping Mall and Milk Stocks\">Key Risks to Check Before Investing in Tablet Maker, Shopping Mall and Milk Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Final_Thoughts_on_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\" title=\"Final Thoughts on Tablet Maker, Shopping Mall and Milk Stocks\">Final Thoughts on Tablet Maker, Shopping Mall and Milk Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#What_are_tablet_maker_shopping_mall_and_milk_stocks\" title=\"What are tablet maker, shopping mall and milk stocks?\">What are tablet maker, shopping mall and milk stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Which_tablet_maker_shopping_mall_and_milk_stocks_are_covered_in_this_list\" title=\"Which tablet maker, shopping mall and milk stocks are covered in this list?\">Which tablet maker, shopping mall and milk stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Why_do_tablet_maker_shopping_mall_and_milk_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do tablet maker, shopping mall and milk stocks have a strong future roadmap in India?\">Why do tablet maker, shopping mall and milk stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#How_has_Alembic_Pharmaceuticals_performed_financially\" title=\"How has Alembic Pharmaceuticals performed financially?\">How has Alembic Pharmaceuticals performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#How_has_Phoenix_Mills_performed_financially\" title=\"How has Phoenix Mills performed financially?\">How has Phoenix Mills performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#How_has_Dodla_Dairy_performed_financially\" title=\"How has Dodla Dairy performed financially?\">How has Dodla Dairy performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#What_risks_should_investors_check_before_buying_tablet_maker_shopping_mall_and_milk_stocks\" title=\"What risks should investors check before buying tablet maker, shopping mall and milk stocks?\">What risks should investors check before buying tablet maker, shopping mall and milk stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks-roadmap-moraine-list\/#Is_this_list_of_tablet_maker_shopping_mall_and_milk_stocks_investment_advice\" title=\"Is this list of tablet maker, shopping mall and milk stocks investment advice?\">Is this list of tablet maker, shopping mall and milk stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\"><\/span><strong>What Are Tablet Maker, Shopping Mall and Milk Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Tablet maker, shopping mall and milk stocks<\/strong> are listed companies that make branded and generic medicines for India and global markets, own and run large shopping malls and offices, and collect and sell milk, curd and ghee. Their earnings depend on medicine demand, mall footfall and dairy demand.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Tablet_Maker_Shopping_Mall_and_Milk_Stocks_at_a_Glance\"><\/span><strong>Tablet Maker, Shopping Mall and Milk Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/aplltd\/alembic-pharmaceuticals-ltd-share-price-today\">Alembic Pharmaceuticals<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,050.65<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,914<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">35.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/phoenixltd\/the-phoenix-mills-ltd-share-price-today\">Phoenix Mills<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,229<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">68,308<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">41.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">30.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.48<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/dodla\/dodla-dairy-ltd-share-price-today\">Dodla Dairy<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">977.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,064<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.03<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Alembic Pharmaceuticals and Dodla Dairy trade at a <strong>P\/E<\/strong> below the industry P\/E, while Phoenix Mills trades above it, which reflects the growth the market already expects. Readers comparing tablet maker, shopping mall and milk stocks should look at <strong>return on equity<\/strong> and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in tablet maker, shopping mall and milk stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Tablet_Maker_Shopping_Mall_and_Milk_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Tablet Maker, Shopping Mall and Milk Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Tablet maker, shopping mall and milk stocks<\/strong> have a strong roadmap in India because steady demand for medicines, growing footfall in malls and rising demand for packaged dairy keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Pharmaceuticals.<\/strong> Doctors prescribe trusted brands.<\/li>\n<li><strong>Malls.<\/strong> Shoppers return to large retail centres.<\/li>\n<li><strong>Dairy.<\/strong> Households buy milk and curd every day.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Alembic_Pharmaceuticals_Features_Among_These_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\"><\/span><strong>Why Alembic Pharmaceuticals Features Among These Tablet Maker, Shopping Mall and Milk Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the tablet maker, shopping mall and milk stocks on this list, Alembic Pharmaceuticals is a Vadodara-based drug maker that sells generic formulations in the United States, branded medicines in India and active ingredients to other manufacturers.<\/p>\n<p>In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%.<\/p>\n<p>Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a <strong>market capitalisation<\/strong> of Rs 14,914 crore. The stock trades at a <strong>P\/E<\/strong> of 21.6, below the industry P\/E of 35.7.<\/p>\n<p><strong>Roadmap:<\/strong> The company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.<\/p>\n<p><strong>What to watch:<\/strong> Follow new approvals in the United States, the pace of complex generic launches and domestic growth.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Phoenix_Mills_Features_Among_These_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\"><\/span><strong>Why Phoenix Mills Features Among These Tablet Maker, Shopping Mall and Milk Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the pharma brand, retail property and dairy shares on this list, Phoenix Mills owns and operates premium retail malls in major cities under the Phoenix brand and also has commercial, residential and hospitality assets.<\/p>\n<p>The company has a return on equity of 11.1%, a debt to equity ratio of 0.48 and a market capitalisation of Rs 68,308 crore. The stock trades at a P\/E of 41.9, above the industry P\/E of 30.7.<\/p>\n<p>Revenue rose from Rs 1,558 crore in FY22 to Rs 4,594 crore in FY26, a compound annual growth rate of 31.0%. Net profit grew from Rs 248 crore in FY22 to Rs 1,557 crore in FY26, which works out to a compound annual growth rate of 58.3%. In the June 2026 quarter, revenue grew 13.3% year on year to Rs 1,115 crore, while net profit rose 23.0% to Rs 394 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is adding mall space and commercial assets as consumer spending rises. Rental income linked to footfall and consumption supports earnings as the portfolio matures.<\/p>\n<p><strong>What to watch:<\/strong> Track consumption in its malls, new mall openings and rental growth.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Dodla_Dairy_Features_Among_These_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\"><\/span><strong>Why Dodla Dairy Features Among These Tablet Maker, Shopping Mall and Milk Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Dodla Dairy, based in Hyderabad, procures milk from farmers and sells milk and value-added products such as curd, ghee and ice creams across South and East India, with operations in Africa.<\/p>\n<p>Revenue rose from Rs 2,257 crore in FY22 to Rs 4,186 crore in FY26, a compound annual growth rate of 16.7%. Net profit grew from Rs 133 crore in FY22 to Rs 267 crore in FY26, which works out to a compound annual growth rate of 19.1%.<\/p>\n<p>In the June 2026 quarter, revenue grew 18.3% year on year to Rs 1,212 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,064 crore. The stock trades at a P\/E of 24.8, below the industry P\/E of 33.9.<\/p>\n<p><strong>Roadmap:<\/strong> The company is growing its value-added products, widening its geographic coverage and adding procurement strength. Value-added dairy brings better margins than plain milk, and a bigger farmer base secures supply.<\/p>\n<p><strong>What to watch:<\/strong> Track milk procurement prices and the growth in value-added products.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alembic_Pharmaceuticals_vs_Phoenix_Mills_vs_Dodla_Dairy_on_Key_Financials\"><\/span><strong>Alembic Pharmaceuticals vs Phoenix Mills vs Dodla Dairy on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three tablet maker, shopping mall and milk stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Alembic Pharmaceuticals<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,356<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,399<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">671<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Phoenix Mills<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,558<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,594<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">31.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,557<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dodla Dairy<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,257<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,186<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">267<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.4%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Dodla Dairy posts the highest return on equity in this group at 15.9%. Alembic Pharmaceuticals has the largest FY26 revenue at Rs 7,399 crore, and Phoenix Mills shows the fastest revenue growth with a 31.0% compound annual rate. A useful habit with <strong>tablet maker, shopping mall and milk stocks<\/strong> is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Alembic Pharmaceuticals<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,717<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,165<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Phoenix Mills<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">985<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,115<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dodla Dairy<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,024<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,212<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.3%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Tablet Maker, Shopping Mall and Milk Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these tablet maker, shopping mall and milk stocks, the main points are: Long-term pharma brand, retail property and dairy shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Consumer spending.<\/strong> Sales follow festivals, incomes and consumer mood.<\/li>\n<li><strong>Raw material costs.<\/strong> Ingredient and packaging prices can move margins.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter tablet maker, shopping mall and milk stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Tablet_Maker_Shopping_Mall_and_Milk_Stocks\"><\/span><strong>Final Thoughts on Tablet Maker, Shopping Mall and Milk Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Tablet maker, shopping mall and milk stocks<\/strong> reward investors who follow demand trends, order books and margins together. Alembic Pharmaceuticals, Phoenix Mills and Dodla Dairy each have a clear plan to grow. Based on the 17 November 2026 close, Alembic Pharmaceuticals trades at Rs 1,050.65, Phoenix Mills at Rs 2,229 and Dodla Dairy at Rs 977.8. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these tablet maker, shopping mall and milk stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track tablet maker, shopping mall and milk stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_tablet_maker_shopping_mall_and_milk_stocks\"><\/span><strong>What are tablet maker, shopping mall and milk stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Tablet maker, shopping mall and milk stocks are listed companies that make branded and generic medicines for India and global markets, own and run large shopping malls and offices, and collect and sell milk, curd and ghee. Their earnings depend on medicine demand, mall footfall and dairy demand. This list looks at three of them, Alembic Pharmaceuticals, Phoenix Mills and Dodla Dairy, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_tablet_maker_shopping_mall_and_milk_stocks_are_covered_in_this_list\"><\/span><strong>Which tablet maker, shopping mall and milk stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Alembic Pharmaceuticals, Phoenix Mills and Dodla Dairy. Based on the 17 November 2026 close, Alembic Pharmaceuticals traded at Rs 1,050.65, Phoenix Mills at Rs 2,229 and Dodla Dairy at Rs 977.8. Their return on equity ranges from <strong>11.1% to 15.9%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 8.4% to 31.0%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_tablet_maker_shopping_mall_and_milk_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do tablet maker, shopping mall and milk stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> <strong>Tablet maker, shopping mall and milk stocks<\/strong> have a strong roadmap in India because steady demand for medicines, growing footfall in malls and rising demand for packaged dairy keep widening the market for these companies. The main drivers are as follows. Pharmaceuticals. Doctors prescribe trusted brands. Malls. Shoppers return to large retail centres. Dairy. Households buy milk and curd every day. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Alembic_Pharmaceuticals_performed_financially\"><\/span><strong>How has Alembic Pharmaceuticals performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P\/E of 21.6, below the industry P\/E of 35.7. Looking ahead, the company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Phoenix_Mills_performed_financially\"><\/span><strong>How has Phoenix Mills performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,558 crore in FY22 to Rs 4,594 crore in FY26, a compound annual growth rate of 31.0%. Net profit grew from Rs 248 crore in FY22 to Rs 1,557 crore in FY26, which works out to a compound annual growth rate of 58.3%. In the June 2026 quarter, revenue grew 13.3% year on year to Rs 1,115 crore, while net profit rose 23.0% to Rs 394 crore. The company has a return on equity of 11.1%, a debt to equity ratio of 0.48 and a market capitalisation of Rs 68,308 crore. The stock trades at a P\/E of 41.9, above the industry P\/E of 30.7. Looking ahead, the company is adding mall space and commercial assets as consumer spending rises. Rental income linked to footfall and consumption supports earnings as the portfolio matures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Dodla_Dairy_performed_financially\"><\/span><strong>How has Dodla Dairy performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 2,257 crore in FY22 to Rs 4,186 crore in FY26, a compound annual growth rate of 16.7%. Net profit grew from Rs 133 crore in FY22 to Rs 267 crore in FY26, which works out to a compound annual growth rate of 19.1%. In the June 2026 quarter, revenue grew 18.3% year on year to Rs 1,212 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,064 crore. The stock trades at a P\/E of 24.8, below the industry P\/E of 33.9. Looking ahead, the company is growing its value-added products, widening its geographic coverage and adding procurement strength. Value-added dairy brings better margins than plain milk, and a bigger farmer base secures supply.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_tablet_maker_shopping_mall_and_milk_stocks\"><\/span><strong>What risks should investors check before buying tablet maker, shopping mall and milk stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying tablet maker, shopping mall and milk stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Consumer spending. Sales follow festivals, incomes and consumer mood. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_tablet_maker_shopping_mall_and_milk_stocks_investment_advice\"><\/span><strong>Is this list of tablet maker, shopping mall and milk stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are tablet maker, shopping mall and milk stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Tablet maker, shopping mall and milk stocks are listed companies that make branded and generic medicines for India and global markets, own and run large shopping malls and offices, and collect and sell milk, curd and ghee. Their earnings depend on medicine demand, mall footfall and dairy demand. This list looks at three of them, Alembic Pharmaceuticals, Phoenix Mills and Dodla Dairy, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which tablet maker, shopping mall and milk stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Alembic Pharmaceuticals, Phoenix Mills and Dodla Dairy. Based on the 17 November 2026 close, Alembic Pharmaceuticals traded at Rs 1,050.65, Phoenix Mills at Rs 2,229 and Dodla Dairy at Rs 977.8. Their return on equity ranges from 11.1% to 15.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.4% to 31.0%.\"}},{\"@type\":\"Question\",\"name\":\"Why do tablet maker, shopping mall and milk stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Tablet maker, shopping mall and milk stocks have a strong roadmap in India because steady demand for medicines, growing footfall in malls and rising demand for packaged dairy keep widening the market for these companies. The main drivers are as follows. Pharmaceuticals. Doctors prescribe trusted brands. Malls. Shoppers return to large retail centres. Dairy. Households buy milk and curd every day. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Alembic Pharmaceuticals performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 5,356 crore in FY22 to Rs 7,399 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 521 crore in FY22 to Rs 671 crore in FY26, which works out to a compound annual growth rate of 6.5%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 2,165 crore, while net profit rose 12.2% to Rs 172 crore. The company has a return on equity of 11.9%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 14,914 crore. The stock trades at a P\/E of 21.6, below the industry P\/E of 35.7. Looking ahead, the company is moving into complex generics such as injectables and ophthalmic products, which tend to face less competition. Steady growth in the India branded business adds stability.\"}},{\"@type\":\"Question\",\"name\":\"How has Phoenix Mills performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,558 crore in FY22 to Rs 4,594 crore in FY26, a compound annual growth rate of 31.0%. Net profit grew from Rs 248 crore in FY22 to Rs 1,557 crore in FY26, which works out to a compound annual growth rate of 58.3%. In the June 2026 quarter, revenue grew 13.3% year on year to Rs 1,115 crore, while net profit rose 23.0% to Rs 394 crore. The company has a return on equity of 11.1%, a debt to equity ratio of 0.48 and a market capitalisation of Rs 68,308 crore. The stock trades at a P\/E of 41.9, above the industry P\/E of 30.7. Looking ahead, the company is adding mall space and commercial assets as consumer spending rises. Rental income linked to footfall and consumption supports earnings as the portfolio matures.\"}},{\"@type\":\"Question\",\"name\":\"How has Dodla Dairy performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 2,257 crore in FY22 to Rs 4,186 crore in FY26, a compound annual growth rate of 16.7%. Net profit grew from Rs 133 crore in FY22 to Rs 267 crore in FY26, which works out to a compound annual growth rate of 19.1%. In the June 2026 quarter, revenue grew 18.3% year on year to Rs 1,212 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,064 crore. The stock trades at a P\/E of 24.8, below the industry P\/E of 33.9. Looking ahead, the company is growing its value-added products, widening its geographic coverage and adding procurement strength. Value-added dairy brings better margins than plain milk, and a bigger farmer base secures supply.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying tablet maker, shopping mall and milk stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying tablet maker, shopping mall and milk stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Consumer spending. Sales follow festivals, incomes and consumer mood. Raw material costs. Ingredient and packaging prices can move margins. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of tablet maker, shopping mall and milk stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Tablet Maker, Shopping Mall and Milk Stocks with a strong future roadmap: Alembic Pharmaceuticals, Phoenix Mills and Dodla Dairy. Compare price, valuation, return on equity and revenue growth as of 17 November 2026.<\/p>\n","protected":false},"author":29,"featured_media":353151,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[10050,3803,7165,22792,25908,11651,812,25907,25906,22790],"class_list":["post-353152","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-alembic-pharmaceuticals","tag-best-stocks","tag-dodla-dairy","tag-formulations","tag-mall-owner-and-milk-products-stocks","tag-pharma-brand","tag-phoenix-mills","tag-retail-property-and-dairy-shares","tag-shopping-mall-and-milk-stocks","tag-tablet-maker"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["353151"],"rank_math_title":["Tablet Maker, Shopping Mall and Milk Stocks"],"rank_math_description":["Compare 3 tablet maker, shopping mall and milk stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 17 Nov 2026."],"rank_math_focus_keyword":["tablet maker, shopping mall and milk stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-pharmaceuticals-company-shopping-malls-owner-and-dairy-products-company-stocks.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=353152"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353152\/revisions"}],"predecessor-version":[{"id":353153,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353152\/revisions\/353153"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/353151"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=353152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=353152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=353152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}